| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.24 | 2e-13 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-08 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0002 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.16 | 0.0004 |